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  A b s t r a c t
   Background/Aim:  Post-stroke cognitive impairment and dementia may be caused by pure vas-
cular, pure degenerative or mixed disease. The relation between post-stroke cognitive impair-
ment and the combination of vascular pathology and degenerative changes is less evaluated. 
We aimed to evaluate the associations between white matter lesions (WMLs) and patient per-
formance 1 year after stroke on tests of executive functioning, memory and visuospatial func-
tion, adjusted for the effects of lifestyle and disease-related factors, including medial temporal 
lobe atrophy (MTLA).   Methods:  Patients with a first-ever stroke or transient ischemic attack 
were invited to participate in the study. The associations between the cognitive test perfor-
mances and WMLs were studied using linear regression [Trail Making Test B (TMT B) and 10-
word test] and logistic regression (Clock Drawing Test).  Results:  In total, 199 patients completed 
the follow-up. The TMT B (p = 0.029) and the 10-word test (p = 0.014) were significantly associ-
ated with WMLs; however, the Clock Drawing Test (p = 0.19) was not. The TMT B (p = 0.018) and 
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the 10-word test (p ≤ 0.001) were both significantly associated with MTLA.   Conclusion:  Im-
paired executive functioning and memory are significantly associated with WMLs and MTLA. 
The mechanisms explaining post-stroke cognitive impairment are multifactorial, including dif-
ferent types of vascular pathology and coexisting vascular and degenerative changes.
    Copyright © 2012 S. Karger AG, Basel
  Introduction
    Stroke is associated with an increased risk of cognitive impairment and dementia   [1, 2]   
and contributes to cognitive decline in various neurodegenerative dementia disorders   [3] . 
Post-stroke cognitive impairment and dementia may be caused by pure vascular disease, 
pure degenerative disease or the coexistence of vascular and degenerative diseases   [4] . In ad-
dition to evident stroke lesions, post-stroke vascular changes include subcortical white mat-
ter lesions (WMLs), silent lacunar infarctions and cerebral microhemorrhages   [5] . WMLs, 
initially described in 1987  [6]  and named leukoaraiosis  [7] , are defined as areas of high signal 
intensity on T  2 -weighted magnetic resonance imaging (MRI) and are related to variable de-
grees of demyelination, axonal loss and gliosis   [8] .
    WMLs are associated with vascular risk factors, especially hypertension and higher 
age  [9] . Further, WMLs are associated with the development of vascular and mixed demen-
tia in patients with mild cognitive impairment  [10] . Elderly patients with severe WMLs are 
at risk of becoming more dependent in activities of daily living   [11] . Severe post-stroke 
WMLs predict cognitive decline   [12]  and indicate a higher risk of recurrent stroke   [13] . 
WMLs are present in 11–21% of adults aged around 64 years   [14] , in up to 44% of patients 
with stroke or transient ischemic attack (TIA) and in 50–75% of patients with vascular de-
mentia   [15] .
    Executive and visuospatial dysfunctions are associated with severe WMLs, whereas 
memory and language dysfunctions are only weakly associated with WMLs   [16, 17]  . How-
ever, the correlation between specific clinical symptoms and the topographical location of 
WMLs is under debate   [18, 19]  . The relation between post-stroke cognitive impairment and 
the combination of vascular pathology and degenerative changes has not been fully exam-
ined.
    Accordingly, we aimed to evaluate the associations between WMLs and patient perfor-
mance 1 year after stroke on tests measuring executive functioning, memory and visuospa-
tial function. Results were adjusted for the possible effects of lifestyle and disease-related 
factors, including medial temporal lobe atrophy (MTLA) as an indicator of possible neuro-
degenerative disease mechanisms.
  M e t h o d s
  P a r t i c i p a n t s
    All patients with a first-ever stroke or TIA admitted to the Stroke Unit of Bærum Hos-
pital, Vestre Viken Hospital Trust between February 2007 and July 2008 were invited to par-
ticipate in the study. Only those patients who survived the acute phase the first week were 
assessed. The hospital has a policy of admitting all stroke patients directly to the Stroke Unit. 
It serves two counties with a total population of approximately 160,000 inhabitants.
    We excluded patients with subarachnoid hemorrhage, dementia or mild cognitive im-
pairment diagnosed before stroke onset, a history of cognitive decline or cognitive decline 
as indicated by a score of   6  3.7 on the Informant Questionnaire on Cognitive Decline in the 40
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Elderly (IQ-CODE)   [20] , previous stroke or TIA, patients who did not speak Norwegian and 
patients with a remaining life expectancy of less than 1 year as estimated by the treating phy-
sician. The IQ-CODE was filled in by the patient’s spouse, a first-degree relative or a close 
friend. The cut off 3.7 was chosen based on the results of a previous study that reported pre-
stroke cognitive decline with an IQ-CODE score of   6  4.0   [21]  and modified to ensure exclu-
sion of pre-stroke dementia.
  A s s e s s m e n t s
    The primary distinction between ischemic stroke and hemorrhagic stroke was based on 
neuroimaging with cerebral computer tomography (CT). We used the WHO definition of 
stroke and the clinical diagnosis of TIA based on the acute loss of focal cerebral function 
with symptoms lasting less than 24 h  [22] . TIA patients were included since cognitive impair-
ments in TIA patients may persist beyond the resolution of focal symptoms   [23] .
    Cognitive functioning was measured at baseline and after 12 months using the Mini-
Mental State Examination (MMSE)   [24] , the Clock Drawing Test   [25] , the Trail Making Test 
A and B (TMT A and B)   [26]  and the 10-word test including delayed recall from the Repeat-
able Battery for the Assessment of Neuropsychological Status (RBANS) (maximal score 40) 
  [27] . The Clock Drawing Test was dichotomized into correct or incorrect answers (5 vs.   ^  4 
according to Shulman   [25] ). The TMT B was interrupted after 5 min, but we allowed the pa-
tients to continue afterwards if they insisted. All patients tried to perform all tests, including 
the TMT A and TMT B, in the acute phase, but results are only reported from those who 
were able to complete the tests.
  The cognitive assessments were chosen in order to evaluate different cognitive domains. 
The 10-word test is a measure of memory impairment. The Clock Drawing Test primarily 
measures visuospatial functions, while the TMT B measures executive functioning. Cogni-
tive impairment of subcortical vascular origin has traditionally been strongly associated 
with impaired executive functioning, while cognitive impairment of cortical, degenerative 
origin more often affects episodic memory, visuospatial function and praxis. Although sin-
gle tests may measure more than one specific cognitive function, we chose a test battery that 
could assess different cognitive domains.
    Neurological impairment was assessed using the National Institutes of Health Stroke 
Scale (NIHSS)   [28] . The neurological examinations were performed on the first day after ad-
mittance by an experienced stroke physician. The NIHSS was repeated at discharge and at the 
12-month follow-up. We screened for pre-stroke cognitive impairment using the 26-question 
version of the IQ-CODE  [20] , repeated after 12 months. Activities of daily living were assessed 
by the Barthel ADL index  [29] , and global functioning was evaluated by the modified Rankin 
Scale   [29] . Patients with ischemic stroke were classified according to The Trial of Org 10172 
in Acute Stroke Treatment (TOAST) classification   [30]  by a stroke physician.
    Patients underwent an MRI of the brain at the 12-month follow-up. Cerebral atrophy 
was measured according to the method first described by Scheltens et al.   [31] . Based on the 
height of the hippocampal formation and the enlargement of the surrounding cerebrospinal 
fluid spaces, the MTLA is graded from 0 to 4 (MTLA grade 0 = no atrophy; MTLA 4 = high-
est degree of atrophy; MTLA 0–1 are considered normal values).
    WMLs were quantified with a semi-automated method in the Nordic lCE Basis Module 
as described earlier   [32] . The manual placement of regions of interest in known white matter 
fiber tracks is a common method to measure diffusion parameters. This software is preferred 
for this purpose, but other programs for diffusion tensor imaging are available   [33] . In the 
fluid-attenuated inversion recovery images, pixel values in the white matter higher than 2 SD 
above the mean pixel value of the respective slices were defined as WMLs. The total WML 
areas in all slices were added together and multiplied with the slice thickness to obtain the 41
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total WML volume (ml). In this sample, patients with pencil line lesions along the ventricles 
and non-confluent small subcortical lesions did not have a total WML volume exceeding 1.5 
ml. Moderate and severe lesions may represent subcortical ischemic small vessel disease   [16]  . 
  S t a t i s t i c s
    The associations between the cognitive test performances (outcome variables) and 
WMLs (explanatory variable) were studied using linear regression (TMT B and 10-word test) 
and logistic regression (Clock Drawing Test). First, univariate analyses were performed. Sec-
ond, 19 candidate variables were analyzed as possible confounding variables, i.e. age, sex, 
Apo E alleles, MTLA, education, vascular risk factors, etiological subtypes of ischemic stroke, 
neurological deficits as measured by NIHSS and stroke in the left hemisphere (table 2). Only 
predictors assessed at baseline, except for physical activity which was assessed at the follow-
up, were included in the analyses in order to evaluate the effect on cognitive outcomes, 
WMLs and MTLA 12 month after stroke. All explanatory variables with a p value   !  0.20 in 
unadjusted analyses were included in the multivariate regression models. All variables (ex-
cept for WMLs) with a p value  1  0.05 were thereafter removed from the models, one at a time, 
until the final adjusted models were reached. We assessed the interaction between WMLs 
and MTLA for each outcome using regression models that included WMLs, MTLA and their 
product as explanatory variables. We used all data available for each analysis, which ranged 
from n = 148 in multivariable analyses to n = 197 in univariable analyses.
    Statistical analyses were performed with STATA 11. All significance tests were two-
tailed and performed at the 5% level.
  E t h i c s
  The study was approved by the Regional Committee for Ethics in Medical Research and 
by the Data Protection Authorities. All patients gave their written informed consent before 
inclusion. First-degree relatives gave consent on behalf of patients with reduced capacity. 
This procedure was approved by the Ethics Committee.
  R e s u l t s
  B a s e l i n e   C h a r a c t e r i s t i c s
    After inviting 253 patients, 250 agreed to participate in the study. Of these, 23 were ex-
cluded; 12 did not fulfill the inclusion criteria (6 had an IQ-CODE score  6  3.7, 1 did not speak 
Norwegian, 1 had an infarction in the spinal cord, 1 had suffered a previous TIA, 2 withdrew 
their consent and 1 patient died before signing the consent) and 11 patients were diagnosed 
with other disease than stroke.
    Of the 227 remaining patients, 174 (76.7%) had a cerebral infarction, 36 (15.8%) had suf-
fered a TIA and 17 (7.5%) were diagnosed with cerebral hemorrhage. Baseline characteristics 
are listed in   table 1  .
    In total, 199 patients completed the follow-up. Of the 28 patients missing, 19 died and 9 
refused to complete the follow-up period. Further, 182 had an MRI for analysis of WMLs and 
MTLA.
  The estimated associations between WMLs and the tests for different cognitive domains, 
including the potentially confounding variables, are displayed in   table 2  . The cognitive tests 
for executive functioning, memory and visuospatial function after 1 year of follow-up were 
all significantly associated with the degree of WMLs. After fitting multivariable regression 
models including patients’ characteristics, vascular risk factors and stroke characteristics, 
the associations remained statistically significant between the severity of WMLs and the 42
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  Table  1.  P  atients characteristics at baseline and 12 months
 Variable   Baseline 
  (n  =  227) 
 12  months 
  (n  =  199) 
 Demographics 
  Male gender  115 (50.7) 
 Age,  years  72.7812.2 
  Education <9 years  55 (24.2) 
 Stroke  subtype 
  Cerebral infarction  174 (76.7) 
 TIA  36  (15.9) 
  Cerebral hemorrhage  17 (7.5) 
 Risk  factors 
 Hypertension  135  (59.5) 
 Hyperlipidemia  124  (54.6) 
 Diabetes  27  (11.9) 
  Cigarette smoking (present)  51 (22.5) 
  Coronary heart disease  53 (23.3) 
  Atrial fibrillation  75 (33.0) 
  BMI >25  126 (55.5) 
 TOAST  classification 
  Large vessel disease  24 (11.4) 
  Cardioembolic disease  66 (31.4) 
  Small vessel disease  66 (31.4) 
  Stroke of undetermined etiology  54 (25.7) 
 Topography 
  Right hemisphere  85 (37.4) 
  Left hemisphere  115 (50.7) 
  Cerebellum/brain stem  27 (11.9) 
 Assessments 
  NIHSS score on day 1  4.1 (1.0–5.0) 
  NIHSS score at discharge  2.4 (0–2.0)  1.8 (0–1.0) 
  BI score  20.0 (18.0–20.0)  18.6 (19.0–20.0) 
  mRS score  1.0 (0–2.0)  1.3 (1.0–2.0) 
  Cognitive assessments (n) 
 IQ-CODE  3.1080.23 (224)  3.3180.41 (188) 
 MMSE   25.6684.78 (214)    25.8685.8 (194) 
 TMT  A  74.5865.0 (192)  63.3848.9 (185) 
 TMT  B   157.4894.5 (162)    142.4886.7 (160) 
  10 word-test, immediate recall  21.287.1 (203)  23.688.5 (195) 
  10 word-test, delayed recall  4.282.5 (201)*  5.083.1 (195) 
  V  alues denote n (%), median (IQR) or mean 8 SD.
    Hyperlipidemia = Total cholesterol >5 mmol/l or low-density lipoprotein cholesterol >3 mmol/l; Cor-
onary heart disease = previous myocardial infarction or present angina pectoris; BMI = body mass index; 
IQR = interquartile range; BI = Barthel activities of daily living index; mRS = modified Rankin Scale.
  *  15 patients did not complete the delayed recall. This test was introduced a little later in the study. 
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performances on TMT B (p = 0.029) and the 10-word list with immediate recall (p = 0.014), 
but not between WMLs and the Clock Drawing Test (p = 0.19) (  table 2  ).
  In addition, age (p   !   0.001), MTLA (p = 0.018), diabetes (p = 0.006), NIHSS score on day 
1 (p = 0.017) and small vessel disease as cause of the stroke (p = 0.011) were significantly and 
independently associated with the TMT B, whereas low education (p   !   0.001), MTLA (p   !   
0.001), hyperlipidemia (p = 0.011), NIHSS score on day 1 (p = 0.023) and left hemisphere 
  Table 2.  R esults of unadjusted and adjusted regression models for all proposed explanatory variables and the three outcomes
Variable 10-word test TMT B Clock Drawing Test
unadjusted adjusted 
(final model)
unadjusted adjusted 
(final model)
unadjusted adjusted 
(final model)
regression 
coefficients
(95% CI)
p value regression 
coefficients
(95% CI)
p value regression 
coefficients
(95% CI)
p value regression 
coefficients
(95% CI)
p value OR estimate 
(95% CI)
p value OR est  imate 
(95% CI)
p 
value
WMLs –0.30 
(–0.44, –0.17)
<0.001 –0.16 
(–0.28, –0.03)
0.014 3.50 
(1.83, 5.18)
<0.001 1.75 
(0.18, 3.33)
0.029 1.06 
(1.02, 1.10)
0.003 1.03 
(0.99, 1.07)
0.19
Age –0.24 
(–0.33, –0.14)
<0.001 2.82 
(1.80, 3.84)
<0.001 2.09 
(0.94, 3.23)
<0.001 1.06 
(1.03, 1.09)
<0.001 1.06 
(1.02, 1.10)
0.001
Sex
(male = 0)
–1.17 
(–3.59, 1.25)
0.34 6.12 
(–21.5, 33.7)
0.66 3.59 
(1.97, 6.55)
<0.001 3.26 
(1.62, 6.55)
0.001
Number of Apo E 4 
alleles present overall: p = 0.72 overall: p = 0.10 overall: p = 0.62
1 vs. 0 –0.85 
(–3.80, 2.11)
0.57 –36.7 
(–71.3, –2.10)
0.038 0.01 
(–0.16, 0.18)
0.89
2 vs. 0 2.05 
(–5.49, 9.60)
0.59 –27.3 
(–114, 59.1)
0.53 0.22 
(–0.22, 0.66)
0.33
MTLA 
(2–4 vs. 0–1)
–6.26 
(–8.50, –4.02)
<0.001 –4.51 
(–6.67, –2.35)
<0.001 70.9 
(44.3, 97.5)
<0.001 33.0 
(5.86, 60.1)
0.018 3.76 
(1.96, 7.22)
<0.001
Education 
(≤9 years = 0)
6.55 
(3.73, 9.37)
<0.001 4.83 
(2.32, 7.34)
<0.001 –22.3 
(–57.5, 12.8)
0.21 0.58 
(0.29, 1.16)
0.12
Homocysteine 
(mol/l)
–0.25 
(–0.50, –0.009)
0.042 2.45 
(–0.41, 5.32)
0.093 1.01 
(0.95, 1.07)
0.82
Hypertension
(treated)
–3.07 
(–5.51, –0.63)
0.014 30.7 
(3.52, 57.9)
0.027 1.65 
(0.91, 2.99)
0.10
Hyperlipidemia 4.57 
(2.22, 6.92)
<0.001 2.72 
(0.59, 4.85)
0.013 –38.3 
(–65.5, –11.2)
0.006 0.82 
(0.46, 1.45)
0.49
Diabetes –3.84 
(–7.63, –0.06)
0.047 63.7 
(14.9, 112)
0.011 60.4 
(17.2, 104)
0.006 1.61 
(0.66, 3.92)
0.29
Atrial fibrillation
(at present)
–1.11 
(–3.80, 1.57)
0.41 17.1 
(–13.0, 47.2)
0.26 1.00 
(0.54, 1.88)
0.99
Coronary heart 
disease
–2.23 
(–5.06, 0.61)
0.12 45.5 
(13.7, 77.3)
0.005 0.86 
(0.44, 1.71)
0.68
Cigarette 
smoking (at 
present)
–0.14 
(–3.54, 3.26)
0.94 –5.65 
(–45.1, 33.8)
0.78 0.83 
(0.36, 1.90)
0.65
BMI 0.20 
(–0.11, 0.51)
0.21 –1.47 
(–5.22, 2.29)
0.44 0.91 
(0.84, 0.98)
0.018
Physical activity
(min/week)
0.007 
(0.001, 0.01)
0.017 –0.035 
(–0.10, 0.03)
0.27 0.997 
(0.995, 0.999)
0.007
Diagnosis overall: p = 0.010 overall: p = 0.53 overall: p = 0.13
TIA vs. 
infarction
3.63 
(0.36, 6.90)
0.030 –20.7 
(–57.3, 15.9)
0.27 0.40 
(0.16, 0.98)
0.046
Hemorrhage 
vs. infarction
–3.93 
(–8.17, 0.31)
0.069 0.78 
(–53.4, 54.9)
0.98 0.71 
(0.25, 2.03)
0.53
TOAST (small 
vessel disease = 0)
–2.05 
(–4.67, 0.56)
0.12 30.7 
(2.20, 59.2)
0.035 32.9 
(7.69, 58.0)
0.011 1.15 
(0.61, 2.15)
0.67
NIHSS (score on 
day 1) 
–0.62 
(–0.85, –0.38)
<0.001 –0.28 
(–0.53, –0.04)
0.017 5.33 
(0.54, 10.1)
0.029 5.63 
(1.02, 10.2)
0.017 1.15 
(1.07, 1.23)
<0.001 1.12 
(1.04, 1.22)
0.005
Topographic 
location (left = 0)
3.06 
(0.68, 5.44)
0.012 2.59 
(0.58, 4.59)
0.009 –9.21 
(–36.4, 18.0)
0.50 1.00 
(0.56, 1.77)
1.00
  Apo   E = Apolipoprotein E; Hyperlipidemia = total cholesterol >5 mmol/l or low-density lipoprotein cholesterol >3 mmol/l; Coronary heart disease = previous myocar-
dial infarction or present angina pectoris; BMI = body mass index. The values are the regression coefficients for the 10-word test and TMT B (linear regression) and the odds 
ratio for the Clock Drawing Test (logistic regression).  
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stroke (p = 0.012) were significantly and independently associated with the 10-word test. 
Failure on the Clock Drawing Test was significantly associated with increasing age (p = 
0.001), NIHSS score on day 1 (p = 0.005) and female sex (p = 0.001).
    No interaction between WMLs and MTLA was observed for any of the three outcomes 
(all p  6   0.34), indicating that different processes are involved in atrophy and chronic vascu-
lar changes.
  Discussion
    We found that the cognitive tests for both executive functioning (TMT B) and impaired 
memory (10-word test) were significantly associated with WMLs. However, the bivariate as-
sociation between the Clock Drawing Test and WMLs was not statistically significant after 
adjusting for the influence of increasing age, NIHSS score on day 1 and gender.
    The association between deficits in executive functioning and WMLs in stroke patients 
has been reported earlier  [16, 17]  and may be due to chronic cerebral small vessel disease with 
endothelial dysfunction, hypoperfusion and affected blood-brain barrier leading to subse-
quent cell injury   [34, 35]  . Furthermore, our results also indicate an association between im-
paired memory and WMLs after stroke. This contrasts the traditional belief that memory 
disturbances are less severe in vascular dementia than in Alzheimer’s disease   [36] . Previous 
findings regarding non-memory-related cognitive deficits in association with WMLs diverge 
even more  [19] , and in stroke patients, impaired memory has been related to reduced tempo-
ral lobe functioning   [37] . However, vascular changes in the brain can be associated with ex-
ecutive functioning as well as with impaired memory   [14, 38]  , ostensibly due to subcortical 
damage and a disruption of the pathways between gray and white matter. WMLs are related 
to more rapid global functional decline  [39]  and, in the post-stroke situation, may contribute 
to cognitive decline and progression of cognitive dysfunction. In addition, we observed an 
association between reduced performance on the 10-word test and stroke in the left hemi-
sphere, indicating cortical damage affecting language and understanding.
  Both reduced executive functioning and impaired memory were significantly associated 
with MTLA, supporting the theory that a degenerative component plays a central role in 
some patients with post-stroke cognitive impairments   [3] . Vascular lesions may amplify the 
effect of existing degenerative pathology or affect beta-amyloid deposits. Further, MTLA, in 
addition to subcortical vascular changes, seems strongly related to post-stroke executive dys-
function. Our findings support the assumption that white matter changes, vascular lesions 
of the brain and Alzheimer’s disease pathology coexist and give rise to an increased risk of 
post-stroke cognitive impairment   [13, 40]  .
    We observed an association between some vascular risk factors and cognitive impair-
ment; hyperlipidemia was associated with the 10-word test and diabetes with the TMT B. 
Midlife high cholesterol increases the risk of Alzheimer’s disease later in life   [41] , represents 
a well-known risk for vascular disease   [42]  and may indicate a risk for post-stroke cognitive 
impairments of both degenerative and vascular origin, whereas diabetes is one of the tradi-
tional risks for lacunar infarcts   [43] .
    Surprisingly, hypertension was not associated with any of the cognitive tests. Midlife 
hypertension is a risk factor for dementia   [41]  as well as for WMLs   [9] . One explanation for 
our finding may be that we only identified treated hypertension, and the hypertension in our 
patients was mostly well controlled before the stroke. Treatment of vascular risk factors in 
patients with cerebrovascular disease may slow the progression of WMLs  [44]  and, therefore, 
intensive secondary prevention may contribute to preserve cognitive functioning.45
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    Our study has some limitations. We included patients with TIA, and both the incidence 
of cognitive impairment and the WML load are lower in these patients. Limitations also in-
clude the absence of a measure of silent infarcts, microbleeds and global cortical atrophy. In 
addition, WMLs were measured only in volume. A more precise topographical description 
of the lesions could have been even more helpful in understanding the relationship between 
WMLs and cognitive functioning.
    We found that the cognitive tests for both executive functioning (TMT B) and impaired 
memory (10-word test) were significantly associated with WMLs. There was also a signifi-
cant association between impaired executive functioning and memory with MTLA. Our 
findings support the assumption that the mechanisms explaining post-stroke cognitive im-
pairment are multifactorial, including different types of vascular pathology and coexistence 
of vascular and degenerative changes. The relationship between WMLs and MTLA was not 
significant.
  Clinically, it is of importance to determine which patients are at risk of dementia among 
those who survive a stroke. The onset of cognitive impairment may be linked to the initial 
severity of WMLs as well as the pre-stroke degenerative process. This aspect has clinical im-
plications in choosing the most appropriate therapeutic strategy and to start prevention ear-
lier in order to preserve cognition. Treatment requires control of all modifiable risk factors.
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